Kinetics and mechanism of angiotensin phosphorylation by the transforming gene product of Rous sarcoma virus.
We have studied steady state kinetics of phosphorylation of [Val5]angiotensin II by pp60src, the transforming gene product of Rous sarcoma virus. Results of initial rate studies at varying substrate concentrations indicated that the mechanism was sequential; Michaelis constants for ATP and peptide were 7 microM and 0.24 mM, respectively, and Vmax was 1.0 nmol/min/mg. The end product ADP and the ATP analog AMP-PNP were competitive inhibitors at varying ATP concentrations and noncompetitive inhibitors at varying peptide concentrations. A dead-end analog of angiotensin II, [delta Phe4]angiotensin II, was a noncompetitive inhibitor at varying ATP concentrations, but induced substrate inhibition at varying peptide concentrations. The kinetic data allowed us to conclude that the reaction proceeded via an Ordered Bi Bi mechanism with ATP as the first binding substrate. We also presented evidence that, while pp60src contained essential histidine and/or lysine residues in its active site, the mechanism does not involve a phosphoryl enzyme intermediate.
D000804:Angiotensin II / Q000378:metabolism*; D001358:Avian Sarcoma Viruses / Q000201:enzymology / Q000235:genetics*; D002471:Cell Transformation, Neoplastic; D005796:Genes; D005814:Genes, Viral; D007700:Kinetics; D008433:Mathematics; D015688:Oncogene Protein pp60(v-src); D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism*; D014764:Viral Proteins / Q000378:metabolism*
D014764:Viral Proteins; D000804:Angiotensin II; D011494:Protein Kinases; D015688:Oncogene Protein pp60(v-src)